Additional file 1: Table S1. of Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Gant, Christina; Laverman, Gozewijn; Vogt, Liffert; Slagman, Maartje; Heerspink, Hiddo; Waanders, Femke; Hemmelder, Marc; Navis, Gerjan

doi:10.6084/m9.figshare.5726302.v1

12882_2017_789_MOESM1_ESM.docx (19.22 kB)

Additional file 1: Table S1. of Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

journal contribution

posted on 2017-12-20, 05:00 authored by Christina Gant, Gozewijn Laverman, Liffert Vogt, Maartje Slagman, Hiddo Heerspink, Femke Waanders, Marc Hemmelder, Gerjan Navis

Patient characteristics. This Table depicts the patients characteristics of patients included in the study. (DOCX 19Â kb)

Funding

Merck Sharp and Dohme

History

Usage metrics

Keywords

Aldosterone Chronic kidney disease Creatinine clearance RAAS inhibition Systolic blood pressure Dietary sodium restriction

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: Table S1. of Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Funding

Merck Sharp and Dohme

History

Usage metrics

Categories

Keywords

Licence

Exports